Inventor · disambiguated record
Marco Ciufolini
Also filed as: CIUFOLINI MARCO · CIUFOLINI MARCO A
21 granted patents·30 pending applications·269 citations·filing 1997–2024
94Inventor score
Files withNANOVATION THERAPEUTICS INC9UNIV BRITISH COLUMBIA8AB SCIENCE6ARBUTUS BIOPHARMA CORP4A & J SCIENCE CO LTD3
Top patents by PatentIndex Score
51 records- 0197US8722082B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted May 13, 2014·44 cites·25 claims
- 0296US10653780B2Amino lipids and methods for the delivery of nucleic acidsARBUTUS BIOPHARMA CORP·Filed 2015·Granted May 19, 2020·28 cites·20 claims
- 0395US9139554B2Amino lipids and methods for the delivery of nucleic acidsHOPE MICHAEL J·Filed 2009·Granted Sep 22, 2015·113 cites·1 claims
- 0489US8450302B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsCIUFOLINI MARCO·Filed 2011·Granted May 28, 2013·8 cites·7 claims
- 0588US7423055B22-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseasesAB SCIENCE·Filed 2003·Granted Sep 9, 2008·29 cites·30 claims
- 0687US7718676B22-aminoaryloxazole compounds as tyrosine kinase inhibitorsAB SCIENCE·Filed 2004·Granted May 18, 2010·31 cites·17 claims
- 0785US8545877B2Modified drugs for use in liposomal nanoparticlesUNIV BRITISH COLUMBIA·Filed 2013·Granted Oct 1, 2013·2 cites·21 claims
- 0883US12121591B2Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agentsNANOVATION THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·1 cites·10 claims
- 0983US8324410B2Modified drugs for use in liposomal nanoparticlesCULLIS PIETER·Filed 2012·Granted Dec 4, 2012·2 cites·16 claims
- 1083US7816520B25,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agentsFABRE PIERRE DERMO COSMETIQUE·Filed 2005·Granted Oct 19, 2010·4 cites·12 claims
- 1181US8790691B2Modified drugs for use in liposomal nanoparticlesCULLIS PIETER·Filed 2009·Granted Jul 29, 2014·2 cites·17 claims
- 1277US2022074925A1Screening method for selected amino-lipid-containing compositionsARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 1375US2011097720A1Screening method for selected amino lipid-containing compositionsALNYLAM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1474US2020225215A1Screening method for selected amino-lipid-containing compositionsARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 1573US8993573B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2013·Granted Mar 31, 2015·1 cites·10 claims
- 1671US8835435B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsCIUFOLINI MARCO·Filed 2011·Granted Sep 16, 2014·1 cites·15 claims
- 1771US8545876B1Modified drugs for use in liposomal nanoparticlesUNIV BRITISH COLUMBIA·Filed 2013·Granted Oct 1, 2013·0 cites·15 claims
- 1871US2018221279A1Modified drugs for use in liposomal nanoparticlesUNIV BRITISH COLUMBIA·Filed 2018·Application pending·0 cites
- 1971US2024398977A1Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agentsNANOVATION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2068US9968554B2Modified drugs for use in liposomal nanoparticlesUNIV BRITISH COLUMBIA·Filed 2014·Granted May 15, 2018·0 cites·16 claims
- 2168US2018209963A1Screening method for selected amino-lipid-containing compositionsARBUTUS BIOPHARMA CORP·Filed 2017·Application pending·0 cites
- 2267US8568772B2Modified drugs for use in liposomal nanoparticlesUNIV BRITISH COLUMBIA·Filed 2013·Granted Oct 29, 2013·0 cites·23 claims
- 2366US8110591B22-aminoaryloxazole compounds as tyrosine kinase inhibitorsMOUSSY ALAIN·Filed 2010·Granted Feb 7, 2012·1 cites·18 claims
- 2464US2014295449A1Screening method for selected amino lipid-containing compositionsTEKMIRA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2563US2012225434A1Screening method for selected amino lipid-containing compositionsCIUFOLINI MARCO A·Filed 2012·Application pending·0 cites
- 2663US2016274089A1Screening method for selected amino-lipid-containing compositionsTEKMIRA PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 2760US2008255141A12-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2007·Application pending·0 cites
- 2860US2024116862A1Sulfur-containing lipidsUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 2960US2024294462A1Method for the Synthesis of Ionizable Lipids Using a Doubly Alkylated IntermediateNANOVATION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3056US2025188028A1Synthetic Method for Producing Ionizable Amino LipidsNANOVATION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3155US2025162968A1Method for Producing Ionizable Lipids or Intermediates for the Synthesis of Such LipidsNANOVATION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3255US2024374754A1Mrna delivery using lipid nanoparticlesUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 3354US2005239852A12-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2003·Application pending·0 cites
- 3454US2024309048A1Method for preparing micrococcin-based carboxylic acid compound and micrococcin-based carboxylic acid compound prepared therebyA & J SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 3553US2024287015A1Method for Producing an Ionizable LipidNANOVATION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3653US2024277800A1Pharmaceutical composition comprising macrocosine compound and method for preparing macrocosine compoundA & J SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 3752US2024383843A1MC3-Type LipidsNANOVATION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3851US2023416274A1Novel compound, preparation method thereof, and antibiotic composition comprising sameA&J SCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 3951US2024300914A1KC2-Type LipidsNANOVATION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4051US2025304547A1Sulfur-Containing LipidsNANOVATION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4150US2011117125A1Compositions and methods for the delivery of nucleic acidsTEKMIRA PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 4250US2011195985A1Compounds for the treatment of lysosomal storage diseasesHOSPITAL FOR SICK CHILDREN·Filed 2011·Application pending·0 cites
- 4347US9481709B2Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolismOBE THERAPY BIOTECHNOLOGY·Filed 2013·Granted Nov 1, 2016·0 cites·9 claims
- 4445US9908858B2Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virusAVIRAGEN THERAPEUTICS INC·Filed 2013·Granted Mar 6, 2018·0 cites·15 claims
- 4541US6218540B1Process for preparing camptothecinBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Apr 17, 2001·2 cites·1 claims
- 4641US2008039466A12-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase InhibitorsAB SCIENCE·Filed 2005·Application pending·0 cites
- 4741US2015272951A1Compounds for the treatment of lysosomal storage diseasesHOSPITAL FOR SICK CHILDREN·Filed 2015·Application pending·0 cites
- 4839US10780174B2Lipid-linked prodrugsUNIV BRITISH COLUMBIA·Filed 2016·Granted Sep 22, 2020·0 cites·16 claims
- 4939US2022304929A1Lipids for delivery of charged material, formulations thereof and method for making sameINTEGRATED NANOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5037US2022226480A1Lipid conjugate prepared from scaffold moietyINTEGRATED NANOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →